Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Borderline ovarian tumors.

A W. Menzin1

  • 1Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, North Shore University Hospital, North Shore-Long Island Jewish Health System, Manhasset, New York, USA

Primary Care Update for Ob/Gyns
|July 4, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Group A streptococcal pharyngitis.

Primary care update for Ob/Gyns·2020
Same journal

Acute bronchitis: a review of diagnosis and evidence-based management.

Primary care update for Ob/Gyns·2020
Same journal

Interferon therapy in primary care.

Primary care update for Ob/Gyns·2001
Same journal

Conservative management of urinary incontinence in women.

Primary care update for Ob/Gyns·2001
Same journal

Child occupant protection: a summary of current safety recommendations.

Primary care update for Ob/Gyns·2001
Same journal

Rubeola.

Primary care update for Ob/Gyns·2001

Borderline ovarian tumors (BOTs) are rare epithelial ovarian cancers affecting women of reproductive age. These tumors have an excellent prognosis, with surgical management being the primary treatment approach.

Area of Science:

  • Gynecologic Oncology
  • Pathology of Ovarian Neoplasms

Background:

  • Borderline ovarian tumors (BOTs) are a distinct group of epithelial ovarian neoplasms.
  • First described over 70 years ago, BOTs have gained systematic recognition in the last three decades.
  • These tumors predominantly affect women during their reproductive years.

Purpose of the Study:

  • To provide an overview of borderline ovarian tumors.
  • To discuss the current understanding of BOT management.
  • To highlight areas of ongoing research in BOT therapy.

Main Methods:

  • Literature review of studies on borderline ovarian tumors.
  • Analysis of epidemiological data and clinical outcomes.
  • Synthesis of current management strategies and research directions.

Related Experiment Videos

Main Results:

  • BOTs represent a small fraction of epithelial ovarian cancers.
  • Patients with BOTs generally experience an excellent long-term prognosis.
  • Surgical intervention is the cornerstone of BOT management.

Conclusions:

  • Borderline ovarian tumors require careful consideration due to their unique characteristics.
  • The primary treatment modality for BOTs is surgical.
  • The role of adjuvant medical therapy in BOTs remains an active area of research and clinical debate.